Cite
HARVARD Citation
Horn, L. et al. (n.d.). 3010 Phase, randomized trial (CheckMate 057) of nivolumab (NIVO) vs docetaxel (DOC) in advanced non-squamous (non-SQ) non-small cell lung cancer (NSCLC): Subgroup analyses and patient reported outcomes (PROs). European journal of cancer. pp. S599-. [Online].